Bufab Group
25.3.2021 08:57:21 CET | Globenewswire | Press release
PRESS RELEASE, Värnamo March 25, 2021
Bufab’s Annual Report and Sustainability Report for 2020 is now available on the Group’s website www.bufab.com.
For further information, please contact:
Marcus Andersson, CFO, Bufab Group, telephone: +46 370 69 69 66
This information is such that Bufab AB (publ) is obliged to disclose in accordance with the EU’s Market Abuse Regulation. The information was submitted for publication by the aforementioned contacts on March 25, 2021 at 07:30 a.m. CET.
About Bufab
Bufab AB (publ), Corporate Registration Number 556685-6240, is a trading company that offers its customers a full-service solution as Supply Chain Partner for sourcing, quality control and logistics for C-Parts (screws, nuts, etc.). Bufab’s Global Parts ProductivityTM customer offering aims to improve productivity in the customers’ value chain for C-Parts.
Bufab was founded in 1977 in Småland and is an international company with operations in 28 countries. The head office is located in Värnamo, Sweden, and Bufab has about 1,300 employees. Bufab’s net sales for 2020 amounted to SEK 4.8 billion and the operating margin was 10.1 percent. The Bufab share is listed on Nasdaq Stockholm, under the ticker "BUFAB". Please visit www.bufab.com for more information.
Attachments
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ProMIS Neurosciences Inc.6.10.2026 13:05:00 CEST | Press release
ProMIS Neurosciences Appoints Seasoned Alzheimer’s and Neuroscience Executive Ivana Rubino, Ph.D., as Chief Commercial Officer
OKYO Pharma LTD6.10.2026 13:00:00 CEST | Press release
OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain
Octave Intelligence plc6.10.2026 13:00:00 CEST | Press release
Octave to Report Third Quarter 2026 Financial Results on November 12
The Descartes Systems Group Inc6.10.2026 12:45:00 CEST | Press release
Descartes Unveils Next Step in Supply Chain AI with Agent Control Plane
Martela Corporation6.10.2026 12:45:00 CEST | Press release
Final results of Martela Corporation’s directed share issue
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
